Sentient Brands’ Stock Gets The Beauty Treatment from Its Oeuvre Luxury Skincare Lineup…Here’s Why Investors Are Attracted ($SNBH)

May 04 06:06 2022
Sentient Brands' Stock Gets The Beauty Treatment from Its Oeuvre Luxury Skincare Lineup...Here's Why Investors Are Attracted ($SNBH)

Sentient Brands’ (OTC Pink: SNBH, $SNBH) stock is consolidating at the $0.07 level. And the good news for investors is that it could be setting up for another significant run. Indeed, those following SNBH know it has a tendency to do just that, evidenced by a more than 347% intraday spike in March alone. For SNBH, history may repeat. 

After all, Sentient Brands is better positioned than ever to continue penetrating the more than $115 billion luxury skincare market opportunity. And with its Oeuvre CBD and gemstone-infused luxury skincare products leading the way, higher share prices may be in the queue. And for good reasons.

Foremost, Sentient Brands’ mission to take its Oeuvre CBD and gemstone-infused luxury skincare products to a luxury skincare market is a plan in motion. And the reward at stake? Part of a massive $115 billion luxury skincare market expected to grow by 25% a year for the next five years. But here’s where the SNBH play gets more interesting. 

While targeting the entire market puts a $100+ billion-dollar long-term revenue-generating opportunity in play, SNBH believes it can do exceptionally well by playing the small game. But don’t be misled; the “small game” is still considerable and provides a niche market opportunity for the Oeuvre lineup to tap into the specialty CBD skincare market’s current $3.4 billion market opportunity.

Based on the attention being paid to the stock, investors are betting on success. Moreover, with an industry consolidating, success could come faster than many think.

A Consolidating Sector

In fact, with Oeuvre being perhaps the most unique new product to hit the luxury skincare scene, SNBH may already be catching the attention of industry brand behemoths like L’Oréal ($OR.PA), Estée Lauder ($EL), and Procter & Gamble ($PG). Each has been historically receptive to acquiring new assets, especially those niche-focused ones that could create a new product category. 

But it’s not only the industry leaders protecting market share. Smaller, multi-million dollar brands are also in the hunt for emerging brands to maintain their position in an uber-competitive sector where new products tend to attract page headlines in industry publications. Still, interest from either camp puts SNBH in a sweet spot of opportunity.

That results from SNBH’s Oeuvre lineup creating a new market segment by utilizing product formulations unique to everything on the market. How so? By combining CBD and gemstone-infused properties that are earning significant consumer attention. In an industry where being different is good, that could bode well for SNBH and its investors. Better still, Sentient has a world-class executive team that knows how to develop brands and get deals done. 

Hence, revenue growth may also be in fashion. 

Best Of Breed Management Team

In fact, the team at Sentient Brands is more than the best of the breed; they have a proven history of high-profile successes, contributing to brand development and marketing at global brands like Hugo Boss, Victoria’s Secret, Versace, and Bath & Body Works.

It’s a combined level of experience that even the blue chips would envy, and SNBH investors should appreciate the value inherent to the company. Moreover, besides experience, they bring the next most valuable asset- connections. And the ones through CEO George Furlan could be the most beneficial. In fact, his involvement alone could be a significant factor in SNBH’s recent run. 

Furlan previously provided creative, strategic, and operational support to lifestyle companies such as Fleur du Mal, Raleigh Denim Post-Imperial, and Tommy Hilfiger. While excellent for them at the time, the better news is that he is now dedicated to driving SNBH’s shareholder value higher by commercializing its own innovative product lines. Knowing that industry experience combined with brand power is a formula for success, investors appear to be taking advantage of ground-floor stock prices. And while the bulls are starting to run, they could soon stampede. 

That’s not unlikely, especially with a management team and brand capable of penetrating a CBD-infused beauty product space that continues to grow at least 25% per year. And by adding a gemstone component to the formulation, Oeuvre stands out in a crowd in an industry bent on new product discovery and innovation. Hence, Oeuvre being in the right place at the right time, the investment proposition in SNBH is quite compelling.

Video Link:

Right Market, Right Product, Right Time

And Sentient isn’t wasting time getting its message out, starting its most extensive marketing campaign in 2022 to introduce the brand to consumers, with an obvious intent to drive revenues higher and leverage its first-to-market position in a developing segment.

Positive results could materialize sooner than later, noting that Oeuvre’s CBD and gemstone-infused beauty products are inventive and socially conscious. And more than meeting criteria that appeal to its target market and differentiate itself from earlier competitors, it’s, as noted, positioned within a beauty industry in consolidation mode. Thus, poaching market share could do more than drive revenues higher; it would likely attract interest from potential suitors. Why?

Because the behemoths in the sector don’t take well to losing market share. In fact, they tend to respond quickly to stop the loss, which could put SNBH’s Oeuvre into the sights of industry giants like L’Oréal, Estée Lauder, and Procter & Gamble. Remember, these companies continually look to develop or acquire new brands that can give them a quick and competitive advantage in emerging markets. It’s a strategy that makes sense. After all, acquiring successful products mitigates risk, lowers marketing costs, and hurdles many barriers to entry that often squeeze small brands out. It’s the quickest way to take advantage of market opportunities.

For both SNBH and a potential acquirer, the best part of that consideration is that Sentient Brands’ Oeuvre is creating a new product category, generating income, and meeting socially conscious expectations with environmentally friendly manufacturing processes. That could be why SNBH’s share price and volume have been trending sharply higher in recent weeks. Investors may very well be positioning ahead of expected news.

Penetrating Into A Massive Luxury Skincare Market

That’s a potentially wise and timely move. Remember, SNBH can do well by staying focused on just its niche opportunity. But in a market in hypergrowth, they can do better. Women in the United States spend an estimated average of $313 per month on beauty products, contributing to the $511 billion worldwide beauty market in 2021. Better yet, for SNBH and investors, is knowing that while the market is massive today, it’s expected to grow as high as $716.6 billion within the next three years. So, even if acquisitions were not in the near-term cards, SNBH is still ideally positioned to do exceptionally well with its innovative line. 

In other words, SNBH doesn’t need to rely on a potential acquisition to drive growth. They can achieve its goals organically with Oeuvre positioned as the first known luxury skincare product that combines CBD and gemstone properties to provide industry-leading results. The combination helps SNBH target a specialized luxury market, the driving force behind the SNBH opportunity.

In addition, the successful marketing of Oeuvre provides a runway to evaluate strategic opportunities, and whether through acquisition or organic growth, Oeuvre is a value creator that could fuel an almost exponential rise in share price. In an e-commerce market expected to deliver a CAGR of 27.4%, that proposition is indeed in play.

Targeting A Lucrative And Proven Opportunity

Better news, it’s a plan in action. Sentient Brands kicked off 2022 with a marketing campaign focused on forming partnerships with popular influencers on social media platforms such as Instagram, Facebook ($FB), and Pinterest. The campaign’s design conveys that Oeuvre is more than dedicated to creating high-end products entirely through sustainable methods; it also delivers best-in-class results.

Oeuvre’s skincare products are free of toxins, irritants, and undesirable additives like sulfates and petroleum. Furthermore, Oeuvre does not utilize animal testing and is produced cruelty-free. They say it themselves…” Sentient Brands’ objective is to go above and beyond industry standards by ethically and responsibly sourcing all of its skincare components to meet the need for environmentally friendly, ethical, and high-quality products.”

Indeed, the message given is one that a socially-conscious generation of users wants to hear. And it’s one that SNBH is delivering.

Positioned Well For A 2022 Breakout

The bottom line- the sum of SNBH parts equates to an investment proposition that may be too good to ignore. And with the potential to meet and pass bullish sales milestones, that consideration may be best applied sooner than later. With markets weak and the small-cap sector bruised, SNBH share prices today are more than attractive; they present a value opportunity that could return substantial near-term gains.

Of course, the most significant factors contributing to the sum of its parts calculation is that Sentient Brands has the team, the assets, and the foundation to achieve the targeted results. Thus, while 2021 may have been critical to setting the stage for growth, 2022 is the likely period for SNBH to leverage those milestones and transform itself from a new market player into a revenue-generating juggernaut. And with volume often preceding price, investors appear to think that may indeed be the case.


Disclaimers: Shore Thing Media, LLC. (STM, LLC.) is responsible for the production and distribution of this content. STM, Llc. is not operated by a licensed broker, a dealer, or a registered investment adviser. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. Our reports/releases are a commercial advertisement and are for general information purposes ONLY. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The information made available by STM, Llc. is not intended to be, nor does it constitute, investment advice or recommendations. The contributors may buy and sell securities before and after any particular article, report and publication. In no event shall STM, Llc. be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or made available by STM, Llc., including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information in this video, article, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. STM, Llc. strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Readers are advised to review SEC periodic reports: Forms 10-Q, 10K, Form 8-K, insider reports, Forms 3, 4, 5 Schedule 13D. For some content, STM, Llc., its authors, contributors, or its agents, may be compensated for preparing research, video graphics, and editorial content. STM, LLC. has been compensated up to ten-thousand-dollars via wire transfer to produce and syndicate content for Sentient Brands, Inc. for a period lasting one month. As part of that content, readers, subscribers, and website viewers, are expected to read the full disclaimers and financial disclosures statement that can be found on our website by visiting

The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled.

Media Contact
Company Name: STM, LLC.
Contact Person: Michael Thomas
Email: [email protected]
Phone: 973-820-3748
Country: United States